Arkema SA (OTCMKTS:ARKAY – Get Free Report) has been assigned a consensus recommendation of “Reduce” from the six ratings firms that are currently covering the company, Marketbeat Ratings reports. Three investment analysts have rated the stock with a sell recommendation, two have assigned a hold recommendation and one has assigned a buy recommendation to the company.
ARKAY has been the subject of several recent analyst reports. Zacks Research cut shares of Arkema from a “hold” rating to a “strong sell” rating in a research note on Tuesday, January 6th. Citigroup restated a “buy” rating on shares of Arkema in a report on Friday, October 3rd. Barclays lowered Arkema from a “hold” rating to a “strong sell” rating in a research note on Tuesday, November 11th. Finally, Deutsche Bank Aktiengesellschaft lowered Arkema from a “buy” rating to a “hold” rating in a research note on Monday, November 24th.
Get Our Latest Report on ARKAY
Arkema Price Performance
Arkema (OTCMKTS:ARKAY – Get Free Report) last announced its earnings results on Friday, November 7th. The basic materials company reported $1.19 earnings per share for the quarter, beating the consensus estimate of $0.98 by $0.21. The firm had revenue of $2.52 billion during the quarter, compared to the consensus estimate of $2.50 billion. Arkema had a net margin of 1.55% and a return on equity of 5.15%. On average, analysts forecast that Arkema will post 8.36 EPS for the current fiscal year.
Arkema Company Profile
Arkema SA is a global specialty chemicals and advanced materials company headquartered in Colombes, France. Established in 2004 as a spin-off from Total’s chemicals division, the company offers a broad portfolio of high-performance materials designed to improve durability, thermal and chemical resistance, and environmental performance across diverse industries.
Arkema’s operations are organized into four core segments. Adhesive Solutions delivers bonding, sealing, and coating technologies for markets such as packaging, medical devices, and consumer goods.
Featured Articles
- Five stocks we like better than Arkema
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- NEW LAW: Congress Approves Setup For Digital Dollar?
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- A U.S. “birthright” claim worth trillions – activated quietly
Receive News & Ratings for Arkema Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arkema and related companies with MarketBeat.com's FREE daily email newsletter.
